The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genentech
Stock and Other Ownership Interests - Roche
Outcomes by BCL2 and MYC expression and rearrangements in untreated diffuse large B-cell lymphoma (DLBCL) from the POLARIX trial.
 
Franck Morschhauser
Honoraria - Chugai/Roche; Eisai; Roche/Genentech
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; epizyme; Genmab; Gilead Sciences; Novartis; Roche/Genentech; SERVIER
Expert Testimony - Roche/Genentech
 
Yanwen Jiang
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Fabrice Jardin
Honoraria - Celgene; Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Roche
 
Alex Francisco Herrera
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Genmab; Karyopharm Therapeutics; Merck; Regeneron; Seagen; Takeda; Tubulis GmbH
Research Funding - ADC Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Kite, a Gilead company (Inst); Merck (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Laurie Helen Sehn
Honoraria - Abbvie; Acerta Pharma; Amgen; Apobiologix; AstraZeneca; Celgene; Debiopharm Group; Genmab; Gilead Sciences; Incyte; Janssen-Ortho; Karyopharm Therapeutics; Kite, a Gilead company; Lundbeck; Merck; morphosys; Roche/Genentech; Sandoz-Novartis; Seagen; Takeda; Teva; TG Therapeutics; Verastem
Consulting or Advisory Role - Abbvie; Acerta Pharma; Amgen; Amgen; apobiologix; AstraZeneca; Celgene; Debiopharm Group; Genmab; Gilead Sciences; Incyte; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Lundbeck; Merck; MorphoSys; Roche/Genentech; Sandoz-Novartis; Seagen; Takeda; Teva; TG therapeutics; TG Therapeutics; Verastem
Research Funding - Roche/Genentech (Inst); Teva (Inst)
 
Charles Herbaux
Honoraria - Abbvie; Gilead Sciences; Janssen-Cilag; Roche
Research Funding - Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Janssen-Cilag; Roche
 
Christopher Flowers
Consulting or Advisory Role - Abbvie; Bayer; BeiGene; Celgene; Denovo Biopharma; Epizyme; Genentech/Roche; Gilead Sciences; Karyopharm Therapeutics; Pharmacyclics/Janssen; Spectrum Pharmaceuticals
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Alimera Sciences (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Millennium (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst); Xencor (Inst)
 
Tycel Jovelle Phillips
Honoraria - Lymphoma & Myeloma Connect; Seagen
Consulting or Advisory Role - ADC Therapeutics; Bayer; Celgene; Curis; Genentech; Genmab; Gilead Sciences; Incyte; Kite/Gilead; Pharmacyclics; Seagen; TG Therapeutics
Research Funding - Abbvie; Bayer; Pharmacyclics/Janssen
 
Armando López Guillermo
Honoraria - Roche
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; Incyte; Janssen; Kern Pharma; Kite/Gilead; Pfizer; Roche; Takeda
Research Funding - Celgene/Bristol-Myers Squibb; Janssen; Roche
Travel, Accommodations, Expenses - Kite/Gilead; Roche
 
Catherine S. Magid Diefenbach
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Genentech/Roche; Janssen; Merck; MorphoSys; Seagen
Research Funding - Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Janssen (Inst); LAM Therapeutics (Inst); MEI Pharma (Inst); Merck (Inst); Millennium (Inst); Roche/Genentech (Inst); Seagen (Inst); Trillium Therapeutics (Inst)
Expert Testimony - Jim Harmon
 
Gareth Gregory
Consulting or Advisory Role - Clinigen Group; Janssen; Roche/Genentech; Sandoz-Novartis
Speakers' Bureau - Abbvie; Roche/Genentech
Research Funding - BeiGene; Janssen; Merck
Expert Testimony - Janssen
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Novartis; Roche/Genentech
 
Austin Injae Kim
No Relationships to Disclose
 
Anna Maria Barbui
Consulting or Advisory Role - EUSA Pharma; Incyte; Takeda
Travel, Accommodations, Expenses - EUSA Pharma
 
Sandhya Balasubramanian
Employment - Genentech
Stock and Other Ownership Interests - Abbvie; Bristol-Myers Squibb; CVS; Roche
 
Will Harris
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Jamie Hirata
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Joseph N. Paulson
No Relationships to Disclose
 
Calvin Lee
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Georg Lenz
Honoraria - Abbvie; ADC Therapeutics; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Constellation Pharmaceuticals; Genmab/Seattle Genetics; Gilead Sciences; Incyte; Janssen-Cilag; MorphoSys; Novartis; Roche/Genentech
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Genmab/Seattle Genetics; Gilead Sciences; Incyte; Janssen-Cilag; MorphoSys; Novartis; Roche/Genentech
Research Funding - AGIOS; Aquinox; AstraZeneca; Bayer; Gilead Sciences; Janssen-Cilag; MorphoSys; Roche/Genentech; Verastem
Expert Testimony - MorphoSys; Roche
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Janssen-Cilag; Roche/Genentech